REGENCY CENTERS CORP (REG)       66.81  -0.72 (-1.07%)

66.81  -0.72 (-1.07%)

US7588491032 - REIT - After market: 66.81 0 (0%)


Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to REG. REG was compared to 218 industry peers in the Equity Real Estate Investment Trusts (REITs) industry. Both the profitability and the financial health of REG get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, REG is valued expensive at the moment.




Profitability

Profitability Rating

6

The Piotroski-F score of REG is 8.00. This is a very strong score and indicates great health and profitability for REG.
REG has a Return On Assets of 4.18%. This is comparable to the industry average of 4.09%.

REG has a Return On Equity of 7.45%. This is comparable to the industry average of 9.38%.
REG's Profit Margin of 37.75% is in line with the rest of the industry. The industry average Profit Margin is 32.35%.
VS Industry

ROA (4.18%) VS Industry: 51% outperformed.

0.02
28.72

ROE (7.45%) VS Industry: 42% outperformed.

0.04
125.88

Profit Margin (37.75%) VS Industry: 58% outperformed.

0.16
684.56

Valuation

Valuation Rating

3

Compared to an average industry Price/Earning Ratio of 25.31, REG is valued in line with its industry peers.
REG's PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
With a price book ratio of 1.87, REG is valued correctly.
When comparing the Enterprise Value to EBITDA ratio of REG to the average industry ratio of 17.41, REG is valued in line with its industry peers.

With a Price/Earnings Ratio of 25.31, REG can be considered very expensive at the moment.
The Forward Price/Earnings Ratio of 32.47 indicates a quite expensive current valuation of REG.
When comparing the price book ratio of REG to the average industry price book ratio of 1.30, REG is valued more expensive than its industry peers.
VS Industry

Price/Earnings (25.31) VS Industry: 50% outperformed.

322.50
0.88

Price/Book (1.87) VS Industry: 34% outperformed.

101.06
0.07

Enterprise Value/ EBITDA (19.15) VS Industry: 44% outperformed.

145.99
3.20

Growth

Growth Rating

5

REG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.38%, which is quite impressive.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
REG shows quite a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 13.67% yearly.
Measured over the past 5 years, REG shows a small growth in Earnings Per Share. The EPS has been growing by 1.69% on average per year.

The Earnings Per Share is expected to grow by 3.99% on average over the next 5 years.
Looking at the last year, REG shows a small growth in Revenue. The Revenue has grown by 6.98% in the last year.
The Revenue is expected to grow by 3.69% on average over the next 5 years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS1.69% 13.06% 35.38% 19% -1.25% 3.1% 3.99%
Revenue13.67% 1.33% 6.98% 4.01% 3.18% 3.48% 3.7%

Health

Health Rating

5

The Debt to Equity ratio of REG is way better than the industry averages. REG has a better rating than 83% of its industry peers.
The Altman-Z score of REG is much better than the industry average of 0.81.
The Piotroski-F score of REG is 8.00. This is a very strong score and indicates great health and profitability for REG.
REG has a Current Ratio of 0.59. This is a bad value and indicates that REG is not financially healthy enough and could expect problems in meeting its short term obligations.

Compared to an average industry Current Ratio of 0.76, REG is worse placed to pay its short term obligations than its industry peers.
REG has a Quick Ratio of 0.59. This is a bad value and indicates that REG is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Quick Ratio of 0.72, REG is worse placed to pay its short term obligations than its industry peers.
REG has an Altman-Z score of 1.43. This is a bad value and indicates that REG is not financially healthy and even has some risk of bankruptcy.
VS Industry

Debt/Equity (0.61) VS Industry: 83% outperformed.

69.38
0.00

Quick Ratio (0.58) VS Industry: 40% outperformed.

0.00
22.38

Current Ratio (0.59) VS Industry: 39% outperformed.

0.00
22.38

Altman-Z (1.43) VS Industry: 75% outperformed.

-1.24
14.37

Dividend

Dividend Rating

5

REG has a Yearly Dividend Yield of 4.04%, which is a nice return.
REG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
REG has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of REG has a limited annual growth rate of 2.78%.

REG's Dividend Yield is slightly below the industry average, which is at 4.85.
The Dividend Rate of REG has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
REG pays out 92.80% of its income as dividend. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (4.04%) VS Industry: 31% outperformed.

0.27
22.70

REGENCY CENTERS CORP66.81

NASDAQ:REG (2/3/2023, 7:04:44 PM)-0.72 (-1.07%)

After market: 66.81 0 (0%)

Chartmill FA Rating
GICS Sector Real Estate
GICS IndustryGroup Real Estate
GICS Industry Equity Real Estate Investment Trusts (REITs)
Earnings (Last) 11-03 2022-11-03/amc Earnings (Next) 02-08 2023-02-08/amc
Inst Owners 95.67% Inst Owner Change -9.19%
Ins Owners 0.51% Ins Owner Change -0.75%
Market Cap 11.43B Analysts 74.17
Price Target 70.86 (6.06%)

Dividend
Industry RankSector Rank
Dividend Yield 4.04%
Dividend Growth(5Y) 2.78% DP 92.8%
Div Incr Years 9 Div Non Decr Years 12
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 22.44%
Min EPS beat(2) 10.17% Max EPS beat(2) 34.71%
EPS beat(4) 3 Avg EPS beat(4) 47.02%
Min EPS beat(4) -16.26% Max EPS beat(4) 159.44%
Revenue beat(2) 2 Avg Revenue beat(2) 2.77%
Min Revenue beat(2) 2.61% Max Revenue beat(2) 2.94%
Revenue beat(4) 4 Avg Revenue beat(4) 3.63%
Min Revenue beat(4) 2.61% Max Revenue beat(4) 5.78%
PT rev (1m) 1.11% PT rev (3m) 4.01%
EPS NQ rev (1m) -0.54% EPS NQ rev (3m) 0.36%
EPS NY rev (1m) 0% EPS NY rev (3m) 1.4%
Revenue NQ rev (1m) -0.68% Revenue NQ rev (3m) 0.23%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.58%

Valuation
Industry RankSector Rank
PE 25.31
Fwd PE 32.47
P/S 9.48
P/FCF 1322.01
P/OCF 16.83
P/B 1.87
P/tB 1.99
EV/EBITDA 19.15
EPS(TTM) 2.64 EY 3.95%
EPS(NY) 2.06 Fwd EY 3.08%
FCF(TTM) 0.05 FCFY 0.08%
OCF(TTM) 3.97 OCFY 5.94%
SpS 7.05 BVpS 35.74
TBVpS 33.57 PEG (NY) 1.33
PEG (5Y) 14.94

Profitability
Industry RankSector Rank
ROA 4.18%
ROE 7.45%
ROIC 3.61%
ROICexc 3.67%
ROICexgc 3.81%
OM 38.97%
PM 37.75%
GM 71.9%
ROICexgc(3y) 2.94% ROICexcg growth 3Y 6.61%
ROICexcg growth 5Y -1.65% ROICexc(3y) 2.82%
ROICexc growth 3Y 7.74% ROICexc growth 5Y -1.8%
OM growth 3Y 4.56% OM growth 5Y 2.44%
PM growth 3Y 11.73% PM growth 5Y 5.76%
GM growth 3Y -0.33% GM growth 5Y -0.48%
F-Score 8 Asset Turnover 0.11

Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 431.25
Debt/EBITDA 4.76
Cap/Depr 213.63%
Profit Quality 1.9%
Current Ratio 0.59
Quick Ratio 0.58
Altman-Z 1.43
F-Score 8 WACC 7.86%
ROIC/WACC 0.48 Cap/Depr(3y) 132.78%
Cap/Depr(5y) 131.04% Profit Quality(3y) 210.06%
Profit Quality(5y) N/A

Growth
EPS 1Y 35.38% EPS 3Y 13.06%
EPS 5Y 1.69% EPS growth Q2Q -26.09%
EPS Next Y 19% EPS Next 2Y -1.25%
EPS Next 3Y 3.1% EPS Next 5Y 3.99%
Revenue growth 1Y 6.98% Revenue growth 3Y 1.33%
Revenue growth 5Y 13.67% Revenue growth Q2Q -1.1%
Revenue Next Year 4.01% Revenue Next 2Y 3.18%
Revenue Next 3Y 3.48% Revenue Next 5Y 3.7%
EBIT growth 1Y 17.18% EBIT growth 3Y 5.95%
EBIT growth 5Y 16.45% EBIT Next Year 77.44%
EBIT Next 3Y 22.77% EBIT Next 5Y 14.09%
FCF growth 1Y -96.26% FCF growth 3Y -33.44%
FCF growth 5Y N/A OCF growth 1Y 28.99%
OCF growth 3Y 2.61% OCF growth 5Y 17.28%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA